Bacterial Vaginosis and Subclinical Markers of Genital Tract Inflammation and Mucosal Immunity

Andrea Ries Thurman, Thomas Kimble, Betsy Herold, Pedro M M Mesquita, Raina N. Fichorova, Hassan Y. Dawood, Titilayo Fashemi, Neelima Chandra, Lorna Rabe, Tina D. Cunningham, Sharon Anderson, Jill Schwartz, Gustavo Doncel

Research output: Contribution to journalArticle

26 Scopus citations

Abstract

Bacterial vaginosis (BV) has been linked to an increased risk of human immunodeficiency virus (HIV) acquisition and transmission in observational studies, but the underlying biological mechanisms are unknown. We measured biomarkers of subclinical vaginal inflammation, endogenous antimicrobial activity, and vaginal flora in women with BV and repeated sampling 1 week and 1 month after completion of metronidazole therapy. We also compared this cohort of women with BV to a healthy control cohort without BV. A longitudinal, open label study of 33 women with a Nugent score of 4 or higher was conducted. All women had genital swabs, cervicovaginal lavage (CVL) fluid, and cervicovaginal biopsies obtained at enrollment and received 7 days of metronidazole treatment. Repeat sampling was performed approximately 1 week and 1 month after completion of therapy. Participant's baseline samples were compared to a healthy, racially matched control group (n=13) without BV. The CVL from women with resolved BV (Nugent 0-3) had significantly higher anti-HIV activity, secretory leukocyte protease inhibitor (SLPI), and growth-related oncogene alpha (GRO-α) levels and their ectocervical tissues had significantly more CD8 cells in the epithelium. Women with persistent BV after treatment had significantly higher levels of interleukin-1β, tumor necrosis factor alpha (TNF-α), and intercellular adhesion molecule 1 (ICAM-1) in the CVL. At study entry, participants had significantly greater numbers of CCR5+ immune cells and a higher CD4/CD8 ratio in ectocervical tissues prior to metronidazole treatment, compared to a racially matched cohort of women with a Nugent score of 0-3. These data indicate that BV is associated with changes in select soluble immune mediators, an increase in HIV target cells, and a reduction in endogenous antimicrobial activity, which may contribute to the increased risk of HIV acquisition.

Original languageEnglish (US)
Pages (from-to)1139-1152
Number of pages14
JournalAIDS Research and Human Retroviruses
Volume31
Issue number11
DOIs
StatePublished - Nov 1 2015

    Fingerprint

ASJC Scopus subject areas

  • Immunology
  • Virology
  • Infectious Diseases

Cite this

Thurman, A. R., Kimble, T., Herold, B., Mesquita, P. M. M., Fichorova, R. N., Dawood, H. Y., Fashemi, T., Chandra, N., Rabe, L., Cunningham, T. D., Anderson, S., Schwartz, J., & Doncel, G. (2015). Bacterial Vaginosis and Subclinical Markers of Genital Tract Inflammation and Mucosal Immunity. AIDS Research and Human Retroviruses, 31(11), 1139-1152. https://doi.org/10.1089/aid.2015.0006